IRINOTECAN Labatec 100 mg/5ml flac 5 ml
7680592840029
CH-59284
L01XX19
07.16.1.
1 / 3
google
Details
- Product number
- 5928402
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- irinotecani hydrochloridum trihydricum 100 mg, sorbitolum 225 mg, acidum lacticum, acidum hydrochloricum q.s. ad pH, natrii hydroxidum q.s. ad pH, aqua ad iniectabile ad solutionem pro 5 ml corresp. natrium 11.5 mg.
Articles (1)
Irinotecan Labatec 100 mg/5 ml, solution à diluer pour perfusion
Lösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
225.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
11.5 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 116.25
Specialties list
Yes
Generic
Yes
SL addition date:
01/04/2010
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 59284
- Drug name
- Irinotecan Labatec, solution à diluer pour perfusion
- Galenic form
- KOPA
- ATC Code
- L01XX19
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 04/12/2009
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- IRINOTECAN Labatec 100 mg/5ml flac 5 ml
- Description (DE)
- IRINOTECAN Labatec 100 mg/5ml Durchstf 5 ml
- Market launch
- 04/12/2009
- Narcotic (BTM)
- No